Sign In
News Digest /
Ticker: JNJ
Ticker: JNJ
11:12am, Wednesday, Mar 18, 2026
In 2026, Amazon and Nvidia are seen through a new lens as value stocks based on key metrics, challenging the tech-growth label many investors gave them prior.
07:29am, Wednesday, Jan 28, 2026
Morgan Stanley raises Johnson & Johnson's rating and price target, citing a robust pipeline and upgraded earnings estimates, with shares rallying on optimistic growth forecasts.
09:51am, Monday, Jan 26, 2026
Michael Burry warns that the Japanese yen's rebound could disrupt U.S. equities, highlighting currency risks amid shifting global financial dynamics.
08:27am, Wednesday, Jan 21, 2026
A court-appointed special master recommends allowing expert testimony supporting a link between Johnson & Johnson talc products and ovarian cancer, moving the long-running lawsuit closer to trial.
09:18am, Friday, Nov 14, 2025
Bristol-Myers Squibb cuts its Phase 3 Librexia ACS trial for milvexian after interim analysis signals low chance of success, causing a 5.2% premarket stock dip.
09:25am, Monday, Nov 03, 2025
Kimberly-Clark agrees to acquire Kenvue, maker of Tylenol and other staples, in a $40B-plus deal, marking the largest U.S. consumer goods buyout, despite Kenvue's recent challenges.
09:02am, Friday, Oct 03, 2025
Wells Fargo upgrades Johnson & Johnson (JNJ) to overweight, raises PT to $212 from $170 (~14% upside), citing Rybrevant-driven oncology momentum, easing tariff drag and a $55B U.S. onshoring push. Shares +1% premarket; watch margins and drug ramp.
09:21am, Friday, Sep 26, 2025
Premarket: tariff chatter lifts chips & pharma-Intel (INTC) +3.7%, GlobalFoundries (GFS) jumps; J&J (JNJ), Pfizer, Lilly firmer after 100% branded-drug tariff talk. Boeing (BA) up on orders; Wayfair (W) down on furniture tariffs. Volatility likely.
06:38am, Tuesday, Aug 19, 2025
Study: RFK Jr.'s June firing came as ACIP reported conflicts fell to ~5% in 2024; FDA VRBPAC has stayed under 4% since 2010. Traders: the shakeup raises short‑term regulatory uncertainty for vaccine stocks like PFE, MRNA and JNJ.
07:02am, Wednesday, Aug 06, 2025
Trump's tariff moves reshape global trade, easing EU tensions but hiking duties on copper and low-value imports. Key deadlines in August-September may escalate US-China friction and pressure drugmakers like Eli Lilly and Pfizer on pricing.
05:23pm, Thursday, Jul 24, 2025
Johnson & Johnson (NYSE: JNJ) has released its financial results for the fiscal second quarter ending June 29, 2025, demonstrating substantial growth across its business segments despite ongoing challenges.
Financial Highlights:
Sales Growth: Worldwide sales were $23.74 billion, a 5.8% increase ...
09:12am, Wednesday, Jul 16, 2025
Johnson & Johnson (JNJ) beat earnings estimates, raised full-year guidance, and boosted pharma stocks, easing sector worries. Shares rose 3%, signaling renewed investor confidence amid ongoing market volatility.
05:41am, Wednesday, Apr 30, 2025
Merck & Co. plans to invest $1 billion in a Delaware manufacturing plant, enhancing domestic production and creating 4,000 jobs. This facility will produce Keytruda, bolstering Merck's supply chain amid tariff pressures, marking a key move in U.S. pharma manufacturing.
05:08pm, Wednesday, Apr 23, 2025
Johnson & Johnson (NYSE: JNJ) Financial Update - Q1 2025
Key Financial Highlights:
Total Revenue: $21.9 billion, up 2.4% YoY
Net Earnings: $10.999 billion (50.2% of sales), compared to $3.255 billion last year
Earnings Per Share (EPS): $4.57 (basic), $4.54 (diluted)
Gross Profit Margin: 66.4%, d...
05:47am, Monday, Apr 14, 2025
Upcoming earnings for the week of April 15-21, 2025, feature key reports from Bank of America (BAC), Johnson & Johnson (JNJ), Taiwan Semiconductor (TSM), UnitedHealth Group (UNH), and Netflix (NFLX). Market watchers should monitor these releases for insights into company performance and market tr...
09:59am, Friday, Mar 21, 2025
Johnson & Johnson (NYSE: JNJ) plans to invest over $55 billion in U.S. manufacturing, unveiling four new plants, starting with a $2 billion facility in North Carolina. This move responds to potential drug import tariffs, signaling a trend in domestic production.
09:11am, Monday, Jan 20, 2025
Key earnings reports are set for January 21-24, 2025. Companies like Netflix, Procter & Gamble, Johnson & Johnson, General Electric, and American Express will announce results critical for market insights. Stay tuned for updates!
05:13am, Monday, Jan 20, 2025
Donald Trump's inauguration as the 47th U.S. president ignites stock market movements as traders anticipate executive actions impacting immigration, inflation, and Fed interest rates. While markets are closed for MLK Day, investors eye upcoming earnings reports and oil price fluctuations.
08:54am, Tuesday, Aug 20, 2024
Johnson & Johnson (NYSE: JNJ) plans to acquire medical device firm V-Wave for up to $1.1 billion, with $600 million upfront. This move aims to boost J&J’s medical device sector, signaling potential growth and market competitiveness for traders to watch.
03:14am, Tuesday, Aug 13, 2024
Johnson & Johnson seeks to resolve talc-related lawsuits with a $6.5 billion settlement, supported by over 75% of claimants. Facing skepticism and previous legal hurdles, the company aims to ease its legal burden while investors watch closely for implications on its stock.
08:30am, Friday, Jul 26, 2024
Thorough guide to selecting dividend stocks: focus on sector selection, financial ratios, management quality, risk assessment, and portfolio diversification to balance income and growth opportunities.
09:00am, Wednesday, Jul 17, 2024
Johnson & Johnson (NYSE: JNJ) surpasses Q2 estimates with $2.82 EPS and $22.45B revenue, raising the full-year 2024 outlook. Shares rise 2.1% on strong performance.
07:51am, Wednesday, Jul 17, 2024
Essential insights for Wednesday: Dow hits record highs, rate cut anticipated, Amazon Prime Day sales surge, and crude prices rise due to tight U.S. supplies.
07:57am, Thursday, Jul 11, 2024
Explore our analysis of the 5 Dividend Kings for July 2024, featuring insights on their performance, dividend yields, and long-term investment potential.
06:17am, Friday, Jun 28, 2024
Discover how to identify blue chip stocks using screeners and why they're a smart investment strategy during high inflation periods for stability and growth.
04:07am, Thursday, May 23, 2024
In a strategic move to enhance shareholder value, DuPont de Nemours Inc. (NYSE: DD) announced plans to split into three publicly traded companies. The decision marks a significant shift for the industrial giant and coincides with CEO Ed Breen stepping down from his role.
06:40am, Tuesday, Apr 16, 2024
Johnson & Johnson reported a first-quarter profit that exceeded Wall Street expectations, driven by robust sales of its cancer treatments, particularly its leading blood cancer drug, Darzalex. The company also updated its profit forecasts 2024, reflecting confidence in its portfolio's growth.
02:16pm, Friday, Apr 05, 2024
On Friday, April 5, U.S. stocks surged, led by a strong jobs report and major tech announcements, amid mixed economic signals and market movements.
06:50am, Thursday, Mar 28, 2024
Double bottom patterns signal potential market reversals, marking a key support level after two significant lows. Learn how this "W" shape can indicate the start of an uptrend, offering strategic entry points for traders.